NCT03508310

Brief Summary

The purpose of this project is to beta-test a brief waiting room video intervention that promotes early initiation of antiretroviral treatment among treatment-naïve HIV-positive patients, adherence to antiretroviral treatment and retention in care among HIV-positive patients currently on therapy, sexual risk reduction tailored to HIV-positive persons, and patient-initiated discussion of these topics with their health providers. The video is currently being created, and will be ready for beta-testing by June 1, 2016. Results of the beta-testing will be used to refine and improve the video before dissemination to HIV/AIDS treatment facilities nationally. This video project is being funded by the Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention (DHAP).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,003

participants targeted

Target at P75+ for not_applicable hiv-infections

Timeline
Completed

Started Jun 2016

Shorter than P25 for not_applicable hiv-infections

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2017

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 16, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 25, 2018

Completed
Last Updated

September 17, 2025

Status Verified

September 1, 2025

Enrollment Period

10 months

First QC Date

April 16, 2018

Last Update Submit

September 15, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Antiretroviral therapy (ART) medication adherence (suppression level)

    Adherence was measured by whether viral load suppression (\<200 RNA copies/mL) was achieved

    By 6 months (183 days) after the patient's index (first) visit to the clinic

  • Antiretroviral therapy (ART) medication adherence (undetectable level)

    Adherence was measured by whether viral load suppression (\<50 RNA copies/mL) was achieved

    By 6 months (183 days) after the patient's index (first) visit to the clinic

Secondary Outcomes (2)

  • Treatment initiation

    on, before, or within 7 days after, their index visit, as documented by OAMC visits in patient EMRs.

  • Retention in HIV medical care

    2 or more clinic visits for any reason at least 90 days apart in the past year divided by all active clients who had had at least one such visit in the past year

Study Arms (2)

Intervention

EXPERIMENTAL

29-minute clinic waiting room video intervention that includes three vignettes and a 2-part animation sequence about main characters who model overcoming challenges to optimal HIV care. The video was played on continuous loop in recognition of typically short patient wait times. Waiting room posters used images from the video to direct patients' attention to the video and reinforce prevention messages.

Other: Taking Care of Me Video

Comparison

NO INTERVENTION

Historical comparison condition. Patients were exposed to standard waiting room environment (absent of intervention video and posters).

Interventions

The video's conceptual framework incorporates Social Cognitive Theory, Information-Motivation-Behavioral Skills model, and Social Action Theory, which together address cognitive and behavioral factors related to study outcomes. Storylines embedded prevention messages aimed at increasing treatment initiation (n=9), medication adherence (n=35), retention in care (n=22), partner protection (n=12), and communication with health care providers (n=7).

Intervention

Eligibility Criteria

Age18 Years - 87 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • located in a jurisdiction with high AIDS prevalence;
  • managing more than 500 unique HIV-positive patients annually;
  • serving minority persons such that minimally 55% of the clinic population is African-American and Hispanic/Latino;
  • at least 163 patients have unsuppressed viral load;
  • utilizing an electronic medical record (EMR) system; and
  • not participating in another behavioral intervention research project during the historical comparison data period (August 2015 through May 2016) or during the 10-month intervention period (June 2016 through March 2017).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Neumann MS, Plant A, Margolis AD, Borkowf CB, Malotte CK, Rietmeijer CA, Flores SA, O'Donnell L, Robilotto S, Myint-U A, Montoya JA, Javanbakht M, Klausner JD. Effects of a brief video intervention on treatment initiation and adherence among patients attending human immunodeficiency virus treatment clinics. PLoS One. 2018 Oct 5;13(10):e0204599. doi: 10.1371/journal.pone.0204599. eCollection 2018.

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Mary S. Neumann, PhD

    Centers for Disease Control and Prevention

    PRINCIPAL INVESTIGATOR
  • Aaron Plant, MPH

    Sentient Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Quasi-experimental design, in which the intervention condition (i.e., video and posters) was implemented for 10 months and the historical comparison condition (i.e., standard waiting room environment) was the prior 10-month period.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2018

First Posted

April 25, 2018

Study Start

June 1, 2016

Primary Completion

March 30, 2017

Study Completion

May 17, 2017

Last Updated

September 17, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

When appropriate, data sets will be made available to interested researchers following discussion with study team.

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
To be determined
Access Criteria
To be determined